Tacrolimus capsule (low-dose) ( DrugBank: Tacrolimus )

1 disease

ID	Disease name (Link within this page)	Number of trials
227	Osler disease	1

227. Osler disease

Clinical trials : 56 / Drugs : 72 - (DrugBank : 21) / Drug target genes : 23 - Drug target pathways : 136

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04646356 (ClinicalTrials.gov)	October 20, 2020	20/10/2020	Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)	Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)	Hereditary Hemorrhagic Telangiectasia;Epistaxis Nosebleed	Drug: Tacrolimus capsule (low-dose)	Unity Health Toronto	United States Department of Defense	Recruiting	18 Years	N/A	All	30	Phase 2	Canada

First Previous1Next Last